참고문헌
- World Health Organization (WHO). WHO coronavirus disease (COVID-19) dashboard [Internet]. Geneva: WHO [cited 2020 Dec 8]. Available from: https://covid19.who.int/.
- Gomez I, Seoane J, Varela-Centelles P, Diz P, Takkouche B. Is diagnostic delay related to advanced-stage oral cancer? A metaanalysis. Eur J Oral Sci 2009;117:541-6. https://doi.org/10.1111/j.1600-0722.2009.00672.x
- Halboub E, Al-Maweri SA, Al-Soneidar WA. Utilization of COVID-19 testing for opportunistic screening of oral cancer. Oral Oncol 2020;106:104775. https://doi.org/10.1016/j.oraloncology.2020.104775
- Brody RM, Albergotti WG, Shimunov D, Nicolli E, Patel UA, Harris BN, et al. Changes in head and neck oncologic practice during the COVID-19 pandemic. Head Neck 2020;42:1448-53. https://doi.org/10.1002/hed.26233
- Gupta A, Arora V, Nair D, Agrawal N, Su YX, Holsinger FC, et al. Status and strategies for the management of head and neck cancer during COVID-19 pandemic: Indian scenario. Head Neck 2020;42:1460-5. https://doi.org/10.1002/hed.26227
- Moon SS, Lee K, Park J, Yun S, Lee YS, Lee DS. Clinical characteristics and mortality predictors of COVID-19 patients hospitalized at nationally-designated treatment hospitals. J Korean Med Sci 2020;35:e328. https://doi.org/10.3346/jkms.2020.35.e328
- Forner D, Noel CW, Wu V, Parmar A, Chan KKW, de Almeida JR, et al. Nonsurgical management of resectable oral cavity cancer in the wake of COVID-19: a rapid review and metaanalysis. Oral Oncol 2020;109:104849. https://doi.org/10.1016/j.oraloncology.2020.104849
- Chu C, Sun Y, Pan Y. Immunotherapy is a preferred option for oral cancer patients during COVID-19 pandemic? Oral Oncol 2020;107:104860. https://doi.org/10.1016/j.oraloncology.2020.104860
- Valentini V, Pucci R, Battisti A, Cassoni A. Head and neck cancer cannot wait for this pandemic to end: risks, challenges and perspectives of oral-maxillofacial surgeon during COVID-19. Oral Oncol 2020;106:104758. https://doi.org/10.1016/j.oraloncology.2020.104758